logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Marco Giovannini

university of california, los angeles

58H-index
402Paper Count
1.4WCitation Count
Published Papers 101
Publication Date
logo
Development of a Genetically Engineered Porcine Model of Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS-1)
errCancers
IF4.4
err2026-06-09
err0
errOAAI
errBrian Na; C. Dustin Rubinstein; Jennifer J. Meudt; Fausto J. Rodriguez; Brent P. Lehman; Jamie L. Reichert; Jeremie Vitte; Dhanansayan Shanmuganayagam; Marco Giovannini
errShare
errSave
The importance of better understanding symptom trajectories in the evolving treatment landscape of acute myeloid leukemia
errSupportive Care in Cancer
IF3
err2026-04-01
err0
PREAI
errNiscola, Pasquale; Giovannini, Marco; Efficace, Fabio
errShare
errSave
Early palliative care in older patients with acute myeloid leukemia undergoing novel therapies
errExpert Review of Hematology
IF2.1
err2025-12-01
err1
PREAI
errNiscola, Pasquale; Piccioni, Daniela; Giovannini, Marco
errShare
errSave
Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia
errEXPERT OPINION ON PHARMACOTHERAPY
IF2.7
err2025-11-01
err2
PREAI
errNiscola, Pasquale; Catalano, Gianfranco; Pasqualini, Gloria; Piccioni, Daniela; Giovannini, Marco; Noguera, Nelida Ines
errShare
errSave
EZH2 inhibition as a potential therapeutic avenue in the treatment of meningioma
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errCasaos, Joshua; Vitte, Jeremie; Perryman, Travis; Harary, Maya; Everson, Richard; Giovannini, Marco
errShare
errSave
Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells
errJournal of Neuro-Oncology
IF3.1
err2025-08-13
err0
PREAI
errMatthew Z. Sun; Erick Contreras; Janet Treger; Marisa Imbroane; Joey Orpilla; Myungjun Ko; Jeremy Reynoso; Sara Khattab; Thomas J. Lai; Jonathan E. Tsang; Jeremie Vitte; Marco Giovannini; Linda M. Liau; Robert Prins; Richard G. Everson
errShare
errSave
Menin Inhibitors: New Targeted Therapies for Specific Genetic Subtypes of Difficult-to-Treat Acute Leukemias
errCANCERS
IF4.4
err2025-01-04
err1
errOAAI
errNiscola, Pasquale; Gianfelici, Valentina; Giovannini, Marco; Piccioni, Daniela; Mazzone, Carla; de Fabritiis, Paolo
errShare
errSave
REPURPOSING OF THE ANTI-VIRAL DRUG RIBAVIRIN AS A POTENTIAL MENINGIOMA THERAPEUTIC
errNEURO-ONCOLOGY
IF13.4
err2024-11-11
err0
PREAI
errCasaos, Joshua; Perryman, Travis; Harary, Maya; Vitte, Jeremie; Shah, Shilp; Na, Brian; Giovannini, Marco; Everson, Richard
errShare
errSave
EZH2 INHIBITION AS A POTENTIAL THERAPEUTIC AVENUE IN THE TREATMENT OF MENINGIOMA
errNEURO-ONCOLOGY
IF13.4
err2024-11-11
err0
PREAI
errCasaos, Joshua; Vitte, Jeremie; Perryman, Travis; Harary, Maya; Shah, Shilp; Na, Brian; Everson, Richard; Giovannini, Marco
errShare
errSave
Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells
errBIOMEDICINES
IF3.9
err2024-09-02
err1
errOAAI
errNa, Brian; Haist, Blake; Shah, Shilp R.; Sabiston, Graeme; Jonas, Steven J.; Vitte, Jeremie; Wirz, Richard E.; Giovannini, Marco
errShare
errSave
Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies?
errANNALS OF HEMATOLOGY
IF2.4
err2024-03-09
err1
PREAI
errNiscola, Pasquale; Gianfelici, Valentina; Giovannini, Marco; Piccioni, Daniela; Mazzone, Carla; de Fabritiis, Paolo
errShare
errSave
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
errJOURNAL OF NEURO-ONCOLOGY
IF3.1
err2024-02-19
err2
errOAAI
errNghiemphu, Phioanh Leia; Vitte, Jeremie; Dombi, Eva; Nguyen, Thien; Wagle, Naveed; Ishiyama, Akira; Sepahdari, Ali R.; Cachia, David; Widemann, Brigitte C.; Brackmann, Derald E.; Doherty, Joni K.; Kalamarides, Michel; Giovannini, Marco
errShare
errSave
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2
errNEURO-ONCOLOGY ADVANCES
IF4.1
err2023-04-17
err8
errOAAI
errJordan, Justin T.; Orr, Christina C.; Thalheimer, Raquel D.; Cambillo, Josephine, V; Beauchamp, Roberta L.; Shaikh, Ghalib; Muzikansky, Alona; Stemmer-Rachamimov, Anat; Giovannini, Marco; Kalamarides, Michel; Barker, Fred G.; Ramesh, Vijaya; Plotkin, Scott R.
errShare
errSave
The Neurofibromatosis 2 Protein, Merlin, Regulates Glial Cell Growth in an ErbB2-and Src-Dependent Manner
errMOLECULAR AND CELLULAR BIOLOGY
IF2.7
err2023-03-21
err63
errOAAI
errHoushmandi, S. Sean; Emnett, Ryan J.; Giovannini, Marco; Gutmann, David H.
errShare
errSave
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma
errNATURE COMMUNICATIONS
IF15.7
err2023-03-21
err5
errOAAI
errChiasson-MacKenzie, Christine; Vitte, Jeremie; Liu, Ching-Hui; Wright, Emily A.; Flynn, Elizabeth A.; Stott, Shannon L.; Giovannini, Marco; McClatchey, Andrea I.
errShare
errSave
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
errGENETICS IN MEDICINE
IF6.2
err2022-09-01
err90
errOAAI
errPlotkin, Scott R.; Messiaen, Ludwine; Legius, Eric; Pancza, Patrice; Avery, Robert A.; Blakeley, Jaishri O.; Babovic-Vuksanovic, Dusica; Ferner, Rosalie; Fisher, Michael J.; Friedman, Jan M.; Giovannini, Marco; Gutmann, David H.; Hanemann, Clemens Oliver; Kalamarides, Michel; Kehrer-Sawatzki, Hildegard; Korf, Bruce R.; Mautner, Victor-Felix; MacCollin, Mia; Papi, Laura; Rauen, Katherine A.; Riccardi, Vincent; Schorry, Elizabeth; Smith, Miriam J.; Stemmer-Rachamimov, Anat; Stevenson, David A.; Ullrich, Nicole J.; Viskochil, David; Wimmer, Katharina; Yohay, Kaleb; Huson, Susan M.; Wolkenstein, Pierre; Evans, D. Gareth
errShare
errSave
Deletion of Nf2 in neural crest-derived tongue mesenchyme alters tongue shape and size, Hippo signalling and cell proliferation in a region- and stage-specific manner
errCELL PROLIFERATION
IF5.6
err2021-10-26
err4
errOAAI
errIshan, Mohamed; Chen, Guiqian; Yu, Wenxin; Wang, Zhonghou; Giovannini, Marco; Cao, Xinwei; Liu, Hong-Xiang
errShare
errSave
MET inhibitor capmatinib plus EGFR tyrosine kinase inhibitor nazartinib for EGFR-mutant non-small cell lung cancer
errANNALS OF ONCOLOGY
IF65.4
err2020-09-01
err7
errOAAI
errFelip, E.; Minotti, V.; Soo, R.; Wolf, J.; Solomon, B.; Tan, D. S. W.; Ardizzoni, A.; Lee, D. H.; Sequist, L. V.; Barlesi, F.; Paz-Ares, L.; Rodriguez-Abreu, D.; Garcia Campelo, M. R.; Sprauten, M.; Djentuh, L. O'Sullivan; Belli, R.; Glaser, S.; Zou, M.; Giovannini, M.; Yang, J. C-H.
errShare
errSave
Comparison of clinical outcomes of patients with METDex14 NSCLC treated with first-line capmatinib in the GEOMETRY mono-1 study with those of a cohort of real-world patients
errANNALS OF ONCOLOGY
IF65.4
err2020-09-01
err4
errOAAI
errWolf, J.; Neal, J. W.; Mansfield, A. S.; Doban, V.; Kanakamedala, H.; Wu, W-H.; Joshi, A.; de Jong, E.; Giovannini, M.; Baik, C. S.
errShare
errSave
Capmatinib in patients with METex14-mutated advanced non-small cell lung cancer who received prior immunotherapy: The phase II GEOMETRY mono-1 study
errANNALS OF ONCOLOGY
IF65.4
err2020-09-01
err8
errOAAI
errVansteenkiste, J. F.; Smit, E. F.; Groen, H. J. M.; Garon, E. B.; Heist, R. S.; Hida, T.; Nishio, M.; Kokowski, K.; Grohe, C.; Reguart, N.; Mansfield, A. S.; Robeva, A.; Ghebremariam, S.; Waldron-Lynch, M.; Akimov, M.; Nwana, N.; Giovannini, M.; Wolf, J.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Eric N. Olson
H-index: 224 · Papers: 979
R
Ralph Weissleder
H-index: 200 · Papers: 1.6K
R
Roderick T. Bronson
H-index: 164 · Papers: 1.1K
T
Tyler Jacks
H-index: 158 · Papers: 817
P
Paul Tempst
H-index: 154 · Papers: 369
View more